Page 1 of Clinical Trials for Fallopian Tube Neoplasms, 401 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Last Updated: March 14, 2012
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Primary Peritoneal Neoplasms
2
Completed
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Last Updated: April 7, 2010
Condition(s): Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms
3
Active, not recruiting
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
Last Updated: March 14, 2012
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female
4
Completed
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Last Updated: May 17, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
5
Completed
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Last Updated: July 7, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
6
Terminated
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Last Updated: April 6, 2012
Condition(s): Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
7
Completed
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer
Last Updated: November 6, 2006
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms
8
Recruiting
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Last Updated: February 3, 2011
Condition(s): Fallopian Tube Neoplasms; Ovarian Cancer; Primary Peritoneal
9
Completed
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
Last Updated: September 29, 2006
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
10
Active, not recruiting
A Prospective Trial of COXEN Chemotherapy Prediction
Last Updated: January 3, 2012
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms
11
Completed
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Last Updated: February 28, 2011
Condition(s): Genital Neoplasms, Female; Fallopian Tube Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
12
Completed
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
Last Updated: January 24, 2007
Condition(s): Genital Neoplasms, Female; Fallopian Tube Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
13
Recruiting
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Last Updated: February 14, 2012
Condition(s): Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Primary Peritoneal Neoplasm
14
Recruiting
Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian Cancer
Last Updated: November 15, 2011
Condition(s): Genital Diseases, Female; Ovarian Diseases; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
15
Completed
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients
Last Updated: November 7, 2006
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
16
Completed
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Last Updated: April 13, 2012
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms
17
Completed
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
Last Updated: March 23, 2011
Condition(s): Adenocarcinoma; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
18
Active, not recruiting
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")
Last Updated: February 25, 2011
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasm
19
Completed
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
Last Updated: February 29, 2008
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
20
Completed
Pharmacogenomics of Paclitaxel in Ovarian Cancer
Last Updated: August 4, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Fallopian+Tube+Neoplasms

Page 1 of Clinical Trials for Fallopian Tube Neoplasms, 401 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About